KBC Group NV - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 55 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
KBC Group NV ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$1980.0%200,0000.0%0.00%0.0%
Q2 2023$198
-3.9%
200,0000.0%0.00%0.0%
Q1 2023$206
+3.5%
200,0000.0%0.00%0.0%
Q4 2022$199
-99.9%
200,0000.0%0.00%0.0%
Q3 2022$199,000
+0.5%
200,0000.0%0.00%0.0%
Q2 2022$198,000
-99.5%
200,000
-50.0%
0.00%
-99.3%
Q1 2022$40,316,000
+91.4%
400,000
+100.0%
0.15%
+125.8%
Q4 2021$21,062,000
+20348.5%
200,000
+100.0%
0.07%
Q3 2021$103,000
-50.5%
100,000
-50.0%
0.00%
Q2 2021$208,000
-49.3%
200,000
-50.0%
0.00%
-100.0%
Q1 2021$410,000
-4.7%
400,0000.0%0.00%
Q4 2020$430,000
+105.7%
400,000
+100.0%
0.00%
-100.0%
Q3 2020$209,000
-57.5%
200,000
-50.0%
0.00%
-50.0%
Q2 2020$492,000
+16.0%
400,0000.0%0.00%
-33.3%
Q4 2019$424,000400,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2020
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 23,984,000$24,566,3211.87%
SSI INVESTMENT MANAGEMENT LLC 14,019,000$14,383,1991.01%
PFM Health Sciences, LP 15,000,000$15,427,1850.68%
Sonora Investment Management Group, LLC 6,380,000$6,460,3770.56%
ADVENT CAPITAL MANAGEMENT /DE/ 24,638,000$25,339,6660.48%
Lombard Odier Asset Management (Europe) Ltd 9,000,000$9,099,1800.45%
RWC Asset Management LLP 11,700,000$12,018,5910.37%
MACKAY SHIELDS LLC 10,450,000$10,721,4910.29%
PALISADE CAPITAL MANAGEMENT, LP 10,093,000$10,326,1480.28%
Nicholas Investment Partners, LP 2,940,000$3,016,3780.23%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders